Altamira Therapeutics Ltd. (NASDAQ:CYTO) shares are trading higher Thursday after the company announced highlights from its NASAR clinical trial with Bentrio nasal spray were published in video format ...
HAMILTON, BERMUDA / ACCESS Newswire / / Altamira Therapeutics Ltd. ("Altamira" or the "Company") (OTCID:CYTOF), a company ...
Altamira Therapeutics Ltd (CYTOF) is making significant progress in its RNA delivery business, focusing on nanoparticle formulation and process development. The company has successfully developed ...
$4 million upfront with up to an additional $8 million of aggregate gross proceeds upon the exercise in full for cash of milestone-linked warrants Altamira Therapeutics Ltd. (“Altamira” or the ...
Under the terms of the agreement, Univercells will test a proprietary mRNA vaccine delivered with Altamira’s SemaPhore nanoparticle platform. If the experiments are successful, the companies intend to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results